About Jun Li
Form D filings for Phi Therapeutics from 2019 to 2024 list Jun Li as director.
Jun Li first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Jun Li in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jun Li works with at each company, as listed on that company's latest Form D.
Phi Therapeutics, Inc. · Form D/A, Jun 26, 2024
YV
Yug Varma
Executive officer and director
NG
Neil Giugno
Chief Executive Officer and director
KL
Kevin Law
Director